
Genotypic resistance profiles of HIV-2-treated patients in West Africa
Author(s) -
Charlotte Charpentier,
Serge Eholié,
Xavier Anglaret,
Mélanie Bertine,
Christine Rouzioux,
Véronique Avettand-Fènoël,
Eugène Messou,
Albert Minga,
Florence Damond,
JeanChristophe Plantier,
François Dabis,
Gilles Peytavin,
Françoise BrunVézinet,
Didier Koumavi Ekouévi
Publication year - 2014
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0000000000000244
Subject(s) - interquartile range , viral load , lopinavir , medicine , ritonavir , virology , reverse transcriptase , reverse transcriptase inhibitor , drug resistance , regimen , lentivirus , protease inhibitor (pharmacology) , nucleoside reverse transcriptase inhibitor , gastroenterology , immunology , viral disease , human immunodeficiency virus (hiv) , antiretroviral therapy , biology , polymerase chain reaction , microbiology and biotechnology , biochemistry , gene
To assess the virological response, genotypic resistance profiles, and antiretroviral plasma concentrations in HIV-2 antiretroviral-treated (antiretroviral therapy, ART) patients in Côte d'Ivoire.